Skip directly to local search Skip directly to A to Z list Skip directly to navigation Skip directly to site content Skip directly to page options
CDC Home

Volume 15, Number 12—December 2009

Dispatch

Diagnostic Assay for Rickettsia japonica

Nozomu Hanaoka, Minenosuke Matsutani, Hiroki Kawabata, Seigo Yamamoto, Hiromi Fujita, Akiko Sakata, Yoshinao Azuma, Motohiko Ogawa, Ai Takano, Haruo Watanabe, Toshio Kishimoto, Mutsunori Shirai, Ichiro Kurane, and Shuji AndoComments to Author 
Author affiliations: National Institute of Infectious Diseases, Tokyo, Japan (N. Hanaoka, H. Kawabata, A. Sakata, M. Ogawa, A. Takano, H. Watanabe, T. Kishimoto, I. Kurane, S. Ando); Yamaguchi University School of Medicine, Yamaguchi, Japan (M. Matsutani, Y. Azuma, M. Shirai); Miyazaki Prefectural Institute for Public Health and Environment, Miyazaki, Japan (S. Yamamoto); Ohara General Hospital, Fukushima, Japan (H. Fujita); Gifu University, Gifu, Japan (H. Kawabata, A. Takano, H. Watanabe)

Suggested citation for this article

Abstract

We developed a specific and rapid detection system for Rickettsia japonica and R. heilongjiangensis, the causative agents of spotted fever, using a TaqMan minor groove binder probe for a particular open reading frame (ORF) identified by the R. japonica genome project. The target ORF was present only in R. japonica–related strains.

Rickettsia, a genus that includes the causative agents for spotted fever rickettsioses and typhus fever, comprises obligate intracellular bacteria (1). The first case of Japanese spotted fever (JSF), caused by R. japonica (2), was reported in 1984 in Japan (3). According to the national surveillance system in Japan (http://idsc.nih.go.jp/idwr/ybata/report-Ea.html), JSF cases, including sporadic cases resulting in death, have been gradually increasing. Rapid diagnosis of rickettsial infections is important because rickettsioses can be cured when appropriate antimicrobial drug treatment is given during the early clinical stages of the disease. Furthermore, development of a rapid and specific diagnostic system for R. japonica is now a matter of increasing urgency (4) because JSF has also been reported in several other countries in Asia (1).

The Study

Since 1998, thirteen complete Rickettsia genome sequences have been reported (www.ncbi.nlm.nih.gov/Genbank/index.html). In addition, the National Center for Biotechnology Information (NCBI) genome project for R. japonica strain YH has recently concluded (project ID 38487). Results of this project show specific DNA regions for R. japonica in the Rickettsia genome. One of these regions includes a 216-bp open reading frame (ORF) (GenBank accession no. AB437281). On the basis of information from this genome project, we performed DNA sequencing for this 216-bp ORF to determine whether the specific DNA sequences are conserved in all R. japonica strains and other closely related strains, including R. heilongjiangensis (5) and Rickettsia sp. LON (6).

R. heilongjiangensis is also a causative agent of spotted fever in northeastern Asia and has been classified within the R. japonica group (5). Several studies have reported that Rickettsia. sp. LON strains also have similar sequences to R. japonica. Our PCR can easily distinguish Rickettsia sp. LON strains (LON-2, LON-9, and LON-13) from R. japonica strains. This test can help in the diagnosis because Rickettsia sp. LON strains have only been isolated from ticks and may not be pathogenic in humans (6).

Figure

Thumbnail of Unique DNA sequence in the Rickettsia japonica genome that analyzed PCR in this study. A) Comparative genome map of the 216-bp open reading frame (ORF). The R. japonica–specific sequence region (AB437281) in the R. japonica genome and the complete genome sequence of R. conorii strain Malish 7 were compared. The RC1338 DNA sequence and the mapping position data for R. conorii were obtained from the Rickettsia genome database (www.igs.cnrs-mrs.fr/mgdb/Rickettsia). Two solid black arro

Figure. Unique DNA sequence in the Rickettsia japonica genome that analyzed PCR in this study. A) Comparative genome map of the 216-bp open reading frame (ORF). The R. japonica–specific sequence region (AB437281)...

DNA sequencing was performed by using an ABI PRISM BigDye Terminator version 3.1 Kit (Applied Biosystems, Foster City, CA, USA) with an ABI 3130 sequence detector. DNA sequences were aligned by ClustalW software (http://clustalw.ddbj.nig.ac.jp/top-e.html) with an open gap penalty of 15, a gap extension penalty of 6.66, a gap distance of 8, and a maximum division penalty of 40. For determination of the DNA sequence for the 216-bp ORF, the primer pair of JapoSP5′ (5′-ACAACATCAATATTATAATTAGTATCC-3′) and JapoSP3′ (5′-TTCACGTATGTCTATATATGCTGCAGCG-3′) was used to amplify a 564-bp section, including this ORF, because this unique DNA sequence was located as the inserted sequence of the homolog for R. conorii RC1338 (Figure, panel A).

The nucleotide sequence of this ORF was identical among 5 of the R. japonica strains: DT-1, YH, FLA-1, HH-8, and HH-9 (100%); the sequence was highly conserved with significant identity in R. heilongjiangensis (99.5%), except for the Rickettsia sp. LON strains (92.1%; Figure, panel B). This 216-bp ORF had been previously applied to BLAST searches with NCBI blast (nblast) for humans, mice, and others (http://blast.ncbi.nlm.nih.gov/Blast.cgi). The results showed that no similar ORF had been reported to date. Therefore, we focused on this conserved region of the 216-bp ORF to develop a TaqMan minor groove binder (MGB) probe (Applied Biosystems) that could detect the pathogenic R. japonica group, including R. heilongjiangensis, with a high degree of specificity.

Oligonucleotide primers (SpRija5′ and SPRija3′) and the TaqMan MGB probe (SpRijaMGB) were designed by using Primer Express software version 2.0 (Applied Biosystems Figure, panel B). The detection probe was labeled with the fluorescent reporter FAM (carboxyfluorescein labeling) at the 5′ end; the nonfluorescent quencher and MGB were labeled at the 3′ end (Figure, panel B). The detection sequence (shown as a bold line in Figure, panel B) was registered in GenBank (accession no. AB437281).

Real-time PCR was performed by using an ABI 7500 system (Applied Biosystems). DNA polymerase (perfect real-time PCR) for the PCR was obtained from Takara Bio (Kyoto, Japan). A 20-μL sample was added to each well of a 96-well microplate (Thermo Fisher Scientific Inc., Waltham, MA, USA) according to the manufacturer’s instructions. Thermal cycle protocol was performed as follows: first incubation stage, 20 s at 95°C; second stage, 5 s at 95°C and 34 s at 60°C. The second stage was repeated 45 times. For analysis of real-time PCR, the threshold line was fixed at 0.2 to avoid detection of nonspecific fluorescence. This detection procedure can be completed within 1 h.

The reactivity of this assay was examined by using various copy numbers of synthetic R. japonica DNA fragments that were amplified by the primer pairs JapoSP5′ and JapoSP3′ within the R. japonica genome. Genomic DNA of R. japonica strain YH was prepared from cultivated bacteria according to methods proposed by Furuya et al. (7). A calibration curve was generated with 5 calibrators, ranging from 102 to 109 copies/well in triplicate. We found a linear correlation (R>0.99) between the detection cycle numbers and R. japonica DNA copy numbers from 102 to 109 copies/reaction (data not shown).

A total of 26 rickettsial strains, classified into 11 species, were used in this study (Table 1). Specificities for this TaqMan PCR are also summarized in Table 1. Genomic DNA of R. prowazekii and R. rickettsii were prepared from antigen slides (Panbio Inc., Sinnamon Park, Queensland, Australia) by using a Gentra Puregene kit (QIAGEN, Valencia, CA, USA). Genomic DNA of other Rickettsia strains was also prepared from cultivated bacteria according to methods proposed by Furuya et al. (7).

Our results showed that this novel assay could detect all 5 R. japonica strains and 1 R. heilongjiangensis strain used in this study. However, it could not detect R. rickettsii, R. prowazekii, or other Rickettsia strains. These results indicate that the combination of probes and primers in this study had high specificity for the pathogenic R. japonica group. Nonspecific reactions were not observed when genomic DNA from human or murine fibroblasts was used in any of the assays (data not shown).

The detection limits of this PCR were compared to those of conventional PCRs by using serially diluted genomic DNA. The conventional PCRs, designated as Rj5-Rj10 and R1-R2 assays, were designed to detect the 17-kDa antigen gene of Rickettsia, by using a primer set of Rj5 (5′-CGCCATTCTACGTTACTACC-3′) and Rj10 (5′-ATTCTAAAAACCATATACTG-3′) (7) and R1 (5′-TCAATTCACAACTTGCCATT-3′) and R2 (5′-TTTACAAAATTCTAAAAACC-3′) (15), respectively. Since 1996, these assays have been used for molecular diagnosis of JSF in clinical laboratories in Japan. Recent studies have suggested that a TaqMan PCR assay may be as much as 100× more sensitive than these assays (data not shown). Therefore, in our study, the TaqMan PCR was assumed to be much more sensitive than the conventional assays that are known to show false-negative results, even for a patient with acute-stage JSF.

We requested clinical samples to verify the validity of our assay. Eighteen DNA templates were extracted from blood clots collected from 18 patients in the acute stages of illness (male:female ratio 1:1; average age 64.1 years [range 27–88 years); average number of days after onset of fever 4.6 [range 2–7 days; Table 2]). These templates were reexamined by using our TaqMan PCR. Although the conventional assays could not detect the presence of any Rickettsia DNA, 9 of 18 samples displayed positive results with the TaqMan PCR (Table 2). The blood clot from the patient in whom Scrub typhus disease was previously diagnosed was used as a negative control in this real-time PCR assay, resulted were not detected. Our TaqMan PCR is currently available to clinical laboratories that need to rule out false-negative results in molecular diagnoses.

Conclusions

JSF is a threat to public health in Japan. Our results suggest that an R. japonica–specific 216-bp ORF may have been conserved throughout the R. japonica species and closely related Rickettsia spp. The newly developed real-time PCR system, which demonstrated a high level of sensitivity and specificity, may be a useful tool for laboratory diagnosis.

Dr Hanaoka is a research resident in the Laboratory of Rickettsia and Chlamydia, Department of Virology I, National Institute of Infectious Diseases, Japan. His primary research interests are ecology, epidemiology, etiology, and development of diagnosis for zoonoses, especially vector-borne diseases.

Acknowledgments

We thank Fumihiko Mahara for providing clinical samples. We are also grateful to Mika Shigematsu and John M. Kobayashi for their suggestions and critical reading of the manuscript.

This work was supported by a Health Science research grant for research on emerging and reemerging infectious diseases from the Japan Health Sciences Foundation and a grant from the Emerging and Reemerging Infectious Diseases, Ministry of Health, Labor, and Welfare of Japan.

References

  1. Walker DH. Rickettsiae and rickettsial infections: the current state of knowledge. Clin Infect Dis. 2007;45:S3944. DOIPubMed
  2. Uchida T, Uchiyama T, Kumano K, Walker DH. Rickettsia japonica sp. nov., the etiological agent of spotted fever group rickettsiosis in Japan. Int J Syst Bacteriol. 1992;42:3035. DOIPubMed
  3. Mahara F, Koga K, Sawada S, Taniguchi T, Shigemi F, Suto T, The first report of the rickettsial infections of spotted fever group in Japan: three clinical cases. Kansenshogaku Zasshi. 1985;59:116571.PubMed
  4. Fenollar F, Raoult D. Molecular diagnosis of bloodstream infections caused by non-cultivable bacteria. Int J Antimicrob Agents. 2007;30:S715. DOIPubMed
  5. Fournier PE, Dumler SJ, Greub G, Zhang J, Wu Y, Raoult D. Gene sequence-based criteria for identification of new Rickettsia isolates and description of Rickettsia heilongjiangensis sp. Nov. J Clin Microbiol. 2003;41:545665. DOIPubMed
  6. Fujita H. Cell culture system for isolation of disease agents: 15 years of experience in Ohara Research Laboratory. Annu Rep Ohara Hosp. 2008;48:2142.
  7. Furuya Y, Katayama T, Yoshida Y, Kaiho I. Specific amplification of Rickettsia japonica DNA from clinical specimens by PCR. J Clin Microbiol. 1995;33:4879.PubMed
  8. Fujita H, Fournier PE, Takada N, Saito T, Raoult D. Rickettsia asiatica sp. nov., isolated in Japan. Int J Syst Evol Microbiol. 2006;56:23658. DOIPubMed
  9. Fournier PE, Fujita H, Takada N, Raoult D. Genetic identification of rickettsiae isolated from ticks in Japan. J Clin Microbiol. 2002;40:217681. DOIPubMed
  10. Ishikura M, Ando S, Shinagawa Y, Matsuura K, Hasegawa S, Nakayama T, Phylogenetic analysis of spotted fever group rickettsiae based on gltA, 17-kDa, and rOmpA genes amplified by nested PCR from ticks in Japan. Microbiol Immunol. 2003;47:82332.PubMed
  11. Robertson RG, Wisseman CL Jr. Tick-borne rickettsiae of the spotted fever group in West Pakistan. II. Serological classification of isolates from West Pakistan and Thailand: evidence for two new species. Am J Epidemiol. 1973;97:5564.PubMed
  12. Fournier PE, Takada N, Fujita H, Raoult D. Rickettsia tamurae sp. nov., isolated from Amblyomma testudinarium ticks. Int J Syst Evol Microbiol. 2006;56:16735. DOIPubMed
  13. Perez Gallardo F, Fox JP. Infection of guinea pigs with massive doses of rickettsiae of epidemic and murine typhus. J Immunol. 1948;60:45563.PubMed
  14. Dantas-Torres F. Rocky Mountain spotted fever. Lancet Infect Dis. 2007;7:72432. DOIPubMed
  15. Katayama T, Furuya Y, Yoshida Y, Kaiho I. Spotted fever group rickettsiosis and vectors in Kanagawa Prefecture. Kansenshogaku Zasshi. 1996;70:5618.PubMed

Figure

Tables

Suggested citation for this article: Hanaoka N, Matsutani M, Kawabata H, Yamamoto S, Fujita H, Sakata A, et al. Diagnostic assay for Rickettsia japonica. Emerg Infect Dis [serial on the Internet]. 2009 Dec [date cited]. Available from http://wwwnc.cdc.gov/eid/article/15/12/09-0252.htm

DOI: 10.3201/eid1512.090252

Top of Page

Table of Contents – Volume 15, Number 12—December 2009

Comments to the Authors

Please use the form below to submit correspondence to the authors or contact them at the following address:

Shuji Ando, National Institute of Infectious Diseases – Virology I, 1-23-1 Toyama, Shinjuku, Tokyo 162-8640, Japan





characters(s) remaining.

Comment submitted successfully, thank you for your feedback.

Comments to the EID Editors

Please contact the EID Editors via our Contact Form.

 

Past Issues

Select a Past Issue:

Art in Science - Selections from Emerging Infectious Diseases
Now available for order



CDC 24/7 – Saving Lives, Protecting People, Saving Money. Learn More About How CDC Works For You…

USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO